These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9242365)

  • 1. Actinomycin D treatment leads to differentiation and inhibits proliferation in rhabdomyosarcoma cells.
    Marchal JA; Prados J; Melguizo C; Fernández JE; Vélez C; Alvarez L; Aránega A
    J Lab Clin Med; 1997 Jul; 130(1):42-50. PubMed ID: 9242365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low concentrations of actinomycin D potentially cause therapeutic differentiation in human rhabdomyosarcoma cell line RD.
    Melguizo C; Prados J; Marchal JA; Aránega AE; Alvarez L; Aránega A
    Pathol Res Pract; 1996 Feb; 192(2):188-94. PubMed ID: 8692721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic differentiation in a human rhabdomyosarcoma cell line selected for resistance to actinomycin D.
    Prados J; Melguizo C; Marchal JA; Vélez C; Alvarez L; Aránega A
    Int J Cancer; 1998 Jan; 75(3):379-83. PubMed ID: 9455797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actinomycin D causes multidrug resistance and differentiation in a human rhabdomyosarcoma cell line.
    Melguizo C; Prados J; Fernández JE; Vélez C; Alvarez L; Aránega A
    Cell Mol Biol (Noisy-le-grand); 1994 Mar; 40(2):137-45. PubMed ID: 7911694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ara-C treatment leads to differentiation and reverses the transformed phenotype in a human rhabdomyosarcoma cell line.
    Crouch GD; Kalebic T; Tsokos M; Helman LJ
    Exp Cell Res; 1993 Feb; 204(2):210-6. PubMed ID: 8440318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse expression of mdr 1 and c-myc genes in a rhabdomyosarcoma cell line resistant to actinomycin d.
    Prados J; Melguizo C; Fernández A; Aránega AE; Alvarez L; Aránega A
    J Pathol; 1996 Sep; 180(1):85-9. PubMed ID: 8943821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of a human rhabdomyosarcoma cell line after antineoplastic drug treatment.
    Melguizo C; Prados J; Aneiros J; Fernandez JE; Velez C; Aranega A
    J Pathol; 1995 Jan; 175(1):23-9. PubMed ID: 7891223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells.
    Marchal JA; Prados J; Melguizo C; Gómez JA; Campos J; Gallo MA; Espinosa A; Arena N; Aránega A
    Br J Cancer; 1999 Feb; 79(5-6):807-13. PubMed ID: 10070873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.
    De Giovanni C; Lollini PL; Dolcetti R; Landuzzi L; Nicoletti G; D'Andrea E; Scotland K; Nanni P
    Br J Cancer; 1993 Apr; 67(4):674-9. PubMed ID: 8471424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.
    Codenotti S; Poli M; Asperti M; Zizioli D; Marampon F; Fanzani A
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1717-1730. PubMed ID: 29971532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actin, tropomyosin and alpha-actinin as markers of differentiation in human rhabdomyosarcoma cell lines induced with dimethyl sulfoxide.
    Prados J; Melguizo C; Fernandez JE; Aranega AE; Alvarez L; Aranega A
    Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):525-36. PubMed ID: 8374504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of new 5-fluorouracil antitumor cell differentiating derivatives.
    Domínguez JF; Marchal JA; Correa A; Carrillo E; Boulaiz H; Aránega A; Gallo MA; Espinosa A
    Bioorg Med Chem; 2003 Feb; 11(3):315-23. PubMed ID: 12517427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells.
    Astolfi A; De Giovanni C; Landuzzi L; Nicoletti G; Ricci C; Croci S; Scopece L; Nanni P; Lollini PL
    Gene; 2001 Aug; 274(1-2):139-49. PubMed ID: 11675006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and actinomycin D induces apoptosis even in TRAIL-resistant human pancreatic cancer cells.
    Matsuzaki H; Schmied BM; Ulrich A; Standop J; Schneider MB; Batra SK; Picha KS; Pour PM
    Clin Cancer Res; 2001 Feb; 7(2):407-14. PubMed ID: 11234897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of myogenic differentiation in a human rhabdomyosarcoma cell line by a new derivative of 5-fluorouracil (QF-3602).
    Marchal JA; Melguizo C; Prados J; Aránega AE; Gómez JA; Campos J; Gallo MA; Espinosa A; Arena N; Aránega A
    Jpn J Cancer Res; 2000 Sep; 91(9):934-40. PubMed ID: 11011122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low sample volume causes differentiation in human rhabdomyosarcoma cell line RD subjected to electroporation.
    Aránega A; Marchal JA; Melguizo C; Prados J; Aránega AE; Vélez C; Fernández JE; Arena N; Alvarez L
    Cell Mol Biol (Noisy-le-grand); 1996 Dec; 42(8):1219-27. PubMed ID: 8997525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo.
    Vucenik I; Kalebic T; Tantivejkul K; Shamsuddin AM
    Anticancer Res; 1998; 18(3A):1377-84. PubMed ID: 9673344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP effects on myogenic gene expression in rhabdomyosarcoma cells.
    Wasserman LM; Newsham I; Huang HJ; Cavenee WK
    Exp Cell Res; 1996 Aug; 227(1):55-62. PubMed ID: 8806451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-trans-retinoic acid inhibits the growth of human rhabdomyosarcoma cell lines.
    Crouch GD; Helman LJ
    Cancer Res; 1991 Sep; 51(18):4882-7. PubMed ID: 1893378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.